State Controller Calls for Audit Of Stem Cell Institute's Expenditures
By Joyce E. Cutler,
Bureau of National Affairs
| 11. 29. 2007
[Quotes CGS's Jesse Reynolds]
California Controller John Chiang (D) Nov. 28 called for an audit of all proceeds of the California Institute for Regenerative Medicine (CIRM), the voter-created office overseeing $3 billion in bonds sold to fund stem cell research.
Chiang announced the audit while chairing the annual meeting of the Citizens Financial Accountability Oversight Committee with results due in time for the committee's meeting next spring.
The controller, noting that $250 million in bonds already were sold, directed his staff to audit grant management, financial risk, expenditures, and procedures for avoiding conflicts of interest.
Chiang also asked the state Fair Political Practices Commission (FPPC) for a full review of whether Independent Citizens' Oversight Committee member John Reed violated conflict-of-interest rules. Reed wrote a letter asking why CIRM denied a grant to a scientist who works for him at the Burnham Institute for Medical Research in La Jolla, Calif.
The ICOC is CIRM's governing board. Members are required to refrain from participating in or influencing decisions involving their employers. No changes resulted from Reed's letter, interim CIRM President Richard Murphy said.
Chiang said it...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...